UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004777
Receipt number R000005688
Scientific Title Study of the effect of nutrition management on gastrointestinal mucosa and absorption after esophagectomy in esophageal cancer patient
Date of disclosure of the study information 2011/04/01
Last modified on 2014/12/24 22:19:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of the effect of nutrition management on gastrointestinal mucosa and absorption after esophagectomy in esophageal cancer patient

Acronym

Study of the effect of nutrition management after esophagectomy

Scientific Title

Study of the effect of nutrition management on gastrointestinal mucosa and absorption after esophagectomy in esophageal cancer patient

Scientific Title:Acronym

Study of the effect of nutrition management after esophagectomy

Region

Japan


Condition

Condition

esophageal cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effect of total parenteral nutrition and enteral nutrition on gastrointestinal mucosa and absorption

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II,III


Assessment

Primary outcomes

Change ratio of diamin oxidase (DAO) activity on the day before operation and 3rd and 7th day after operation

Key secondary outcomes

Change of serum albumin, total protein and trace element concentration on the day before operation and 3rd and 7th day after operation


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Total parental nutrition

Interventions/Control_2

enteral nutrition

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

1) histlogically confirmed esophageal cancer
2) planning to undergo transthoracic esophagectomy and stomach reconstruction
3) WBC: 3000 /mm3>=, =<12000/mm3
and NE: >=1500 mm3
and PLT: >=100000 /mm3
and Hb: >=9.5 g/dL
and GOT, GPT: < 1.5 times of institutional upper limit
and T-Bil: =<1.5 g/dL
and ALP: < 2.5 times of institutional upper limit
and Cr: =<1.5 mg/dL
and Alb: >=2.8g/dL
4) Written informed concent

Key exclusion criteria

1) history of receiving gastrectomy
2) taking trace element
3) liver disease, mental disease, convulsive seizure, seizure disorder, heart disease, hemoglobinopathy, hemophilia, uncontrolled diabetes mellitus, autoimmune disease
4) history of severe adverse event due to ELNEOPA(R) or RACOL(R)
5) contraindication to ELNEOPA(R) or RACOL(R)
6) pregnancy
7) judged inadequate to this study by chief doctor

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Morihito Okada

Organization

Hiroshima University Hospital

Division name

Surgical Oncology

Zip code


Address

1-2-3 kasumi, Minami-ku, Hiroshima

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Hiroshima University Hospital

Division name

Surgical Oncology

Zip code


Address

1-2-3 kasumi, Minami-ku, Hiroshima

TEL


Homepage URL


Email



Sponsor or person

Institute

Surgical Oncology, Hiroshima University Hospital

Institute

Department

Personal name



Funding Source

Organization

Surgical Oncology, Hiroshima University Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

広島大学病院(広島県)


Other administrative information

Date of disclosure of the study information

2011 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2010 Year 12 Month 20 Day

Date of IRB


Anticipated trial start date

2011 Year 02 Month 01 Day

Last follow-up date

2014 Year 11 Month 30 Day

Date of closure to data entry

2014 Year 11 Month 30 Day

Date trial data considered complete

2014 Year 12 Month 24 Day

Date analysis concluded

2014 Year 12 Month 24 Day


Other

Other related information



Management information

Registered date

2010 Year 12 Month 22 Day

Last modified on

2014 Year 12 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005688


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name